{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:30:19Z","timestamp":1788348619551,"version":"build-2803163510"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Andrology"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Patients with cancer are treated with chemotherapeutics that cause adverse effects, including erectile dysfunction (ED).<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We investigated erectile function in rats after the administration of anticancer agents based on data retrieved through mining of the US Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>The statistical signal strength for the association between anticancer drugs and ED was calculated using the reporting odds ratio (ROR). A drug\u2013event combination was detected when the lower limit of the 95% confidence interval (CI) of the ROR exceeded 1.00. Rats were administered anticancer agents detected in the FDA AERS analysis. Erectile function was assessed using intracavernous pressure (ICP) and mean arterial pressure (MAP) analysis after electrical stimulation of the cavernous nerve. Statistical significance was determined using Welch's <jats:italic>t<\/jats:italic>\u2010test or two\u2010way ANOVA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Melphalan (L\u2010PAM; ROR\u00a0=\u00a04.72, 95% CI\u00a0=\u00a02.78\u20138.00), vincristine (VCR; ROR\u00a0=\u00a02.47, 95% CI\u00a0=\u00a01.54\u20133.97), docetaxel (DTX; ROR\u00a0=\u00a02.25, 95% CI\u00a0=\u00a01.28\u20133.95), methotrexate (MTX; ROR\u00a0=\u00a01.96, 95% CI\u00a0=\u00a01.39\u20132.75), and doxorubicin (DOX; ROR\u00a0=\u00a01.82, 95% CI\u00a0=\u00a01.07\u20133.19) enhanced ED risk. L\u2010PAM and MTX decreased the ICP\/MAP ratio 1\u00a0week after administration. VCR and DOX decreased erectile function 4\u00a0weeks after administration. DTX decreased erectile function at all assessed time points.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and conclusion<\/jats:title><jats:p>Certain anticancer agents should be considered risk factors for ED.<\/jats:p><jats:p>Our results provide possible treatment strategies for maintaining erectile function in cancer survivors, including careful erectile function monitoring after treatment.<\/jats:p><\/jats:sec>","DOI":"10.1111\/andr.13094","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T17:10:41Z","timestamp":1628961041000},"page":"166-178","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Influence of anticancer agents on sexual function: An in vivo study based on the US FDA Adverse Event Reporting System"],"prefix":"10.1111","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-4680","authenticated-orcid":false,"given":"Tomoya","family":"Kataoka","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmaceutics, Graduate School of Medical Sciences Nagoya City University  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5168-3011","authenticated-orcid":false,"given":"Akimasa","family":"Sanagawa","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences Nagoya City University  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences Nagoya City University  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Muto","sequence":"additional","affiliation":[{"name":"Department of Regulatory Science, Graduate School of Pharmaceutical Sciences Nagoya City University  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hotta","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences Nagoya City University  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawade","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences Nagoya City University  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences Nagoya City University  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tohkin","sequence":"additional","affiliation":[{"name":"Department of Regulatory Science, Graduate School of Pharmaceutical Sciences Nagoya City University  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmaceutics, Graduate School of Medical Sciences Nagoya City University  Nagoya Japan"},{"name":"Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences Nagoya City University  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0037875"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2017.08.001"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.13030"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.07.040"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.11.053"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.1514"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.668"},{"key":"e_1_2_11_10_1","unstructured":"FDA's Adverse Event Reporting System:http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/[accessed January 30 2015]."},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02799-9"},{"key":"e_1_2_11_12_1","unstructured":"Guidance for Industry: Good Pharmacovigilance practices and pharmacoepidemilogic Assessment. URL:http:\/\/www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/UCM126834.pdf[accessed January 5 2016]."},{"key":"e_1_2_11_13_1","unstructured":"DrugBank home page URL:http:\/\/www.drugbank.ca\/ [accessed February 17 2015]"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225060-00009"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1429"},{"issue":"2","key":"e_1_2_11_16_1","first-page":"94","article-title":"The influence of enterosorption on some haematological and biochemical indices of the normal rats after single injection of melphalan","volume":"36","author":"Shevchuk OO","year":"2014","journal-title":"Exp Oncol"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/gel066"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11076"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22111911"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2016.01.009"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2017.11.001"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12447"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2013.21"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.02153.x"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14556"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.00854.x"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30965"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0284-4"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.72935"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2020.04.390"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.08.048"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.0894"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1407-6"},{"issue":"6","key":"e_1_2_11_35_1","first-page":"624","article-title":"The laboratory rat: relating its age with human's","volume":"4","author":"Sengupta P","year":"2013","journal-title":"Int J Prev Med"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-67202012000100011"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002383"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30168-5"},{"key":"e_1_2_11_39_1","volume-title":"Docetaxel","author":"Farha NG","year":"2020"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-011-0303-6"}],"container-title":["Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/andr.13094","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/andr.13094","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/andr.13094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T01:11:59Z","timestamp":1715649119000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/andr.13094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1111\/andr.13094"],"URL":"https:\/\/doi.org\/10.1111\/andr.13094","archive":["Portico"],"relation":{},"ISSN":["2047-2919","2047-2927"],"issn-type":[{"value":"2047-2919","type":"print"},{"value":"2047-2927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"assertion":[{"value":"2020-12-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}